Liposome glyconanoparticles are composed of a lipid bilayer membrane encapsulating an aqueous core, with glycan molecules attached to their surface. The unique structure of liposome glyconanoparticles endows them with several remarkable properties. They provide increased stability, safeguarding the encapsulated payload from degradation and premature release. The existence of glycan moieties allows for specific recognition and interaction with target cells or tissues, facilitating targeted drug delivery and enhanced therapeutic efficacy. In diverse applications, liposome glyconanoparticles have demonstrated significant potential. In the realm of medicine, they have been explored for targeted drug delivery to treat diseases like cancer, infectious diseases, and neurodegenerative disorders. Moreover, they show promise in diagnostics, as they can be engineered to carry contrast agents for imaging purposes.
CD BioGlyco is dedicated to leveraging our highly advanced and all-encompassing GlycoNano™ Platform to offer specialized and professional Glyconanoparticle Development Services to our valued clients. With a team of experienced and skilled experts, we ensure that every step of the development process is carried out with meticulous attention to detail to consistently deliver top-quality liposome glyconanoparticle production service. We have extensive experience in providing hydroxycamptothecin chloride chitosan-coated nanoliposome production service.
The preparation of liposome glyconanoparticles typically involves complex yet controlled processes. Techniques such as thin-film hydration, extrusion, and conjugation methods are employed to achieve precise control over particle size, morphology, and surface functionalization.
First of all, the preparation of liposomes is carried out according to your specific needs. Various methods are commonly used for the preparation of liposomes. In the case of thin film hydration, lipids are first dissolved in a suitable organic solvent, which is then removed by specific means to form a thin film. Afterward, the liposomes are hydrated with a buffer solution to successfully prepare the liposomes. Subsequently, we proceed with the modification of the sugar ligands. Throughout the synthesis of the glyconanoparticles, we chemically link the sugar ligands to the lipids. Typically, the strategy employed is to bind the glycan ligand to a lipid that has been modified with polyethylene glycol (PEG). The reason for this approach is that PEG modification can significantly improve the stability of the glyconanoparticles in vivo, as well as enhance their biocompatibility, thus better meeting the needs of practical applications.
We load specific drugs following your precise and individualized needs. The determination of the exact loading method is contingent upon the actual circumstances. For example, selective loading can be achieved through remote loading utilizing an amino sulfate gradient.
The workflow of our liposome glyconanoparticle production service is as follows.
Technologies: Flow cytometry, Fluorescence microscopy
Journal: PloS one
Published: 2012
IF: 2.9
Results: The main research of this article examines how lipid nanoparticles can be utilized to efficiently deliver antigens by targeting the Sialoadhesin/CD169 (Sn/CD169)receptor on the surface of macrophages. It was shown that Sn/CD169 is a macrophage-specific surface receptor that recognizes sialic acid ligands and is conserved in mice and humans. As mentioned in the article, Sn/CD169 is highly expressed in resident macrophages and inflammatory macrophages in tissues, which makes it an ideal receptor for targeting these cells. The researchers developed a lipid nanoparticle decorated with high-affinity Sn/CD169 ligands that were efficiently endocytosed by Sn/CD169-expressing macrophages. The ligand-modified lipid nanoparticles exhibited greater efficiency in delivering antigen compared to conventional anti-Sn antibodies, being able to release antigen in an endosomal acidic environment and accumulate in lysosomes, thereby enhancing antigen presentation and activating specific T cells.
Fig.1 The specificity of Sn-targeted liposomes about a set of siglec-expressing cells. (Chen, et al., 2012)
CD BioGlyco takes pride in presenting our efficient liposome glyconanoparticle production service to our esteemed clients. Our sophisticated techniques and seasoned team guarantee the utmost quality and efficiency during the production process. Have faith in us and contact us to achieve remarkable outcomes in the domain of nanotechnology and biomedicine!
Reference